Saturday, 19 March 2016

#125 Realization of Personalized Drugs (English)

Realization of Personalized Drugs
[TEDxBoston: ‘Body parts on a chip’ by Geraldine Hamilton]

The pharmaceutical industry is always faced with challenges in discovering and developing new drugs. What could be the reasons for the industry to experience supply shock of therapies? The development of new drugs demand vast amount of financial investment and time. More importantly, there is a subtle chance of success.
 
There are two principal techniques available to test the efficacy and the safety: cells in dishes and animal testing. As mentioned beforehand, there are constraints in both of them. In case of cells in dishes, the human cells are placed in dishes and examined in an environment that has no such resemblance of the actual body. The animal testing provides various practical information on the effect on complex organism, however, animal models founder to anticipate the actual effect on human body. As a result, these methods are inadequate for the development of successful drugs as they fundamentally fail to create the dynamic environment of the body.

Wyss Institute, medical research institute, came up with a great solution. The revolutionary invention of “organ-on-a-chip”. An organ-on-a-chip is a multi-channel 3-D microfluidic cell culture chip. This chip is the smallest functioning unit with the function and the mechanical strain that cells experience in our body.
Lung-on-a-chip ⓒ Wyss Institute

1) The white blood cell in the layer of capillary cells
2) The white blood cell going through the pore of the membrane
3) Phagocytosis of the bacterial cell by the white blood cell
ⓒ Wyss Insitute
Observing the lung-on-a-chip, there are three fluidic channels: lung cells on top, porous flexible membrane in the center where cells are cultured, and capillary cells from the blood vessels underneath. The vacuum channels on the sides apply mechanical forces to the chip, so that the cells experience the exact motions as they would in the actual lungs. The bacterial cells are added to the layer of the lung cells, and human white blood cells are released in the layer of the capillary cells. The white blood cells move through the pores of the membrane in the center and reach the other side where they engulf the bacteria (phagocytosis). In fact, the chip has successfully demonstrated the immune response in our body. In other words, chips will create models of diseases and carry out trials on the dynamic responses to potential new treatments. There is a pipeline of chips for different organs such as liver, gut, lungs, heart, and bone marrow. Thus, we can interconnect multiple different chips together to construct a virtual human-on-a-chip.
ⓒ Wyss Institute
In clinical trials, it is impossible to test all the different yet clinical trials-on-a-chip is the perfect solution for this limitation. Simply extract targeted stem cells of the patient and put them on a chip and create a personalized chip to develop drugs that would compensate individual differences.

Reference

KSJ

No comments:

Post a Comment